PROVENTION BIO INC (PRVB) Stock Analyst Earnings Estimates
NASDAQ:PRVB - Nasdaq - US74374N1028 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.395M | 12.895M 824.37% | 44.718M 246.79% | 133.08M 197.60% | 416.71M 213.13% | 504.9M 21.16% | 733.38M 45.25% | 958.8M 30.74% | 1.119B 16.71% | 1.23B 9.92% | ||
| EBITDA YoY % growth | -99.66M | -115.191M -15.58% | -126.933M -10.19% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -99.69M -124.68% | -115.578M -15.94% | -128.161M -10.89% | -159.876M -24.75% | -70.645M 55.81% | 67.069M 194.94% | 126.33M 88.36% | 516.07M 308.51% | 686.15M 32.96% | 767.5M 11.86% | 848.69M 10.58% | |
| Operating Margin | N/A | -8,285.16% | -993.88% | -357.52% | -53.08% | 16.09% | 25.02% | 70.37% | 71.56% | 68.59% | 69.00% | |
| EPS YoY % growth | -1.85 -72.90% | -1.82 1.62% | -1.60 12.09% | -1.90 -18.96% | -0.61 67.71% | 0.87 241.08% | 0.81 -7.06% | 5.62 597.47% | 7.20 28.13% | 8.05 11.76% | 8.89 10.52% |
All data in USD
| Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.88 -152.57% | -0.77 -67.04% | -0.51 -50.00% | -0.33 27.47% |
| Revenue Q2Q % growth | 3.57M 515.52% | 6.63M 788.74% | 9.69M 1,181.75% | 15.674M 44.96% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -75.072M -158.15% | -42.687M -43.09% | -40.698M -39.96% | -26.112M 34.99% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -0.45 -9.76% | -0.47 | 0.02 | 3.79% |
| Q3 2022 Q2Q % growth | -0.34 20.93% | -0.43 | 0.09 | 21.10% |
| Q2 2022 Q2Q % growth | -0.46 | -0.51 | 0.05 | 9.29% |
| Q1 2022 Q2Q % growth | -0.35 32.69% | -0.48 | 0.13 | 26.77% |
| Q4 2021 Q2Q % growth | -0.41 29.31% | -0.46 | 0.05 | 11.24% |
| Q3 2021 Q2Q % growth | -0.43 23.21% | -0.52 | 0.09 | 18.03% |
| Q2 2021 Q2Q % growth | -0.46 -2.22% | -0.53 | 0.07 | 13.55% |
| Q1 2021 Q2Q % growth | -0.52 -100.00% | -0.47 | -0.05 | -10.03% |
| Q4 2020 Q2Q % growth | -0.58 -163.64% | -0.52 | -0.06 | -12.60% |
| Q3 2020 Q2Q % growth | -0.56 -133.33% | -0.44 | -0.12 | -28.53% |
| Q2 2020 Q2Q % growth | -0.45 -40.63% | -0.28 | -0.17 | -59.19% |
| Q1 2020 Q2Q % growth | -0.26 10.34% | -0.26 | 0.00 | -0.62% |
| Q4 2019 Q2Q % growth | -0.22 | -0.24 | 0.02 | 9.18% |
| Q3 2019 Q2Q % growth | -0.24 | -0.30 | 0.06 | 19.79% |
| Q2 2019 Q2Q % growth | -0.32 | -0.32 | 0.00 | -0.13% |
| Q1 2019 Q2Q % growth | -0.29 | -0.19 | -0.10 | -53.68% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 10.813M 1,408.09% | 8.462M | 2.351M | 27.78% |
| Q3 2022 Q2Q % growth | 756K 11.50% | 793.56K | -37.56K | -4.73% |
| Q2 2022 Q2Q % growth | 746K | 710.603K | 35.397K | 4.98% |
| Q1 2022 Q2Q % growth | 580K | 714K | -134K | -18.77% |
| Q4 2021 Q2Q % growth | 717K | 575.688K | 141.312K | 24.55% |
| Q3 2021 Q2Q % growth | 678K | 1.275M | -597K | -46.82% |
| Q2 2021 Q2Q % growth | 1.448M | -1.448M | -100.00% | |
| Q1 2021 Q2Q % growth | 4.437M | -4.437M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -79.31% | -54.76% | -1.57% | -3.75% |
| Revenue | -39.66% | -12.5% | -22.86% | -17.28% |